Garbarg M - Search Results

1

The relationship between functional inhibition and binding for K(Ca)2 channel blockers.

Benton DC, Garbarg M, Moss GW. Benton DC, et al. Among authors: garbarg m. PLoS One. 2013 Sep 10;8(9):e73328. doi: 10.1371/journal.pone.0073328. eCollection 2013. PLoS One. 2013. PMID: 24039913 Free PMC article.

2

Meta-substituted aryl(thio)ethers as potent partial agonists (or antagonists) for the histamine H3 receptor lacking a nitrogen atom in the side chain.

Pelloux-Léon N, Fkyerat A, Piripitsi A, Tertiuk W, Schunack W, Stark H, Garbarg M, Ligneau X, Arrang JM, Schwartz JC, Ganellin CR. Pelloux-Léon N, et al. Among authors: garbarg m. J Med Chem. 2004 Jun 3;47(12):3264-74. doi: 10.1021/jm031141p. J Med Chem. 2004. PMID: 15163206

3

The histamine H3 receptor and its ligands.

Stark H, Arrang JM, Ligneau X, Garbarg M, Ganellin CR, Schwartz JC, Schunack W. Stark H, et al. Among authors: garbarg m. Prog Med Chem. 2001;38:279-308. doi: 10.1016/s0079-6468(08)70096-1. Prog Med Chem. 2001. PMID: 11774797 Review. No abstract available.

4

Enzyme-catalyzed prodrug approaches for the histamine H3-receptor agonist (R)-alpha-methylhistamine.

Stark H, Krause M, Rouleau A, Garbarg M, Schwartz JC, Schunack W. Stark H, et al. Among authors: garbarg m. Bioorg Med Chem. 2001 Jan;9(1):191-8. doi: 10.1016/s0968-0896(00)00237-6. Bioorg Med Chem. 2001. PMID: 11197341

5

Synthesis of potent non-imidazole histamine H3-receptor antagonists.

Ganellin CR, Leurquin F, Piripitsi A, Arrang JM, Garbarg M, Ligneau X, Schunack W, Schwartz JC. Ganellin CR, et al. Among authors: garbarg m. Arch Pharm (Weinheim). 1998 Dec;331(12):395-404. doi: 10.1002/(sici)1521-4184(199812)331:12<395::aid-ardp395>3.0.co;2-7. Arch Pharm (Weinheim). 1998. PMID: 9923195

6

4-Alkynylphenyl imidazolylpropyl ethers as selective histamine H3-receptor antagonists with high oral central nervous system activity.

Krause M, Ligneau X, Stark H, Garbarg M, Schwartz JC, Schunack W. Krause M, et al. Among authors: garbarg m. J Med Chem. 1998 Oct 8;41(21):4171-6. doi: 10.1021/jm9802970. J Med Chem. 1998. PMID: 9767653

7

Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug.

Rouleau A, Garbarg M, Ligneau X, Mantion C, Lavie P, Advenier C, Lecomte JM, Krause M, Stark H, Schunack W, Schwartz JC. Rouleau A, et al. Among authors: garbarg m. J Pharmacol Exp Ther. 1997 Jun;281(3):1085-94. J Pharmacol Exp Ther. 1997. PMID: 9190840

8

Functional relationships between sensory nerve fibers and mast cells of dura mater in normal and inflammatory conditions.

Dimitriadou V, Rouleau A, Trung Tuong MD, Newlands GJ, Miller HR, Luffau G, Schwartz JC, Garbarg M. Dimitriadou V, et al. Among authors: garbarg m. Neuroscience. 1997 Apr;77(3):829-39. doi: 10.1016/s0306-4522(96)00488-5. Neuroscience. 1997. PMID: 9070755

9

Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis.

Rouleau A, Dimitriadou V, Trung Tuong MD, Newlands GF, Miller HR, Schwartz JC, Garbarg M. Rouleau A, et al. Among authors: garbarg m. J Neural Transm (Vienna). 1997;104(4-5):399-417. doi: 10.1007/BF01277659. J Neural Transm (Vienna). 1997. PMID: 9295173 Review.

10

Rat cerebral mast cells undergo phenotypic changes during development.

Dimitriadou V, Rouleau A, Tuong MD, Ligneau X, Newlands GF, Miller HR, Schwartz JC, Garbarg M. Dimitriadou V, et al. Among authors: garbarg m. Brain Res Dev Brain Res. 1996 Nov 22;97(1):29-41. doi: 10.1016/s0165-3806(96)00127-7. Brain Res Dev Brain Res. 1996. PMID: 8946052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page